PHIO FY 2017 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena

PHIOPhio Pharmaceuticals Corp.

$13M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$15,000-21.1% YoY

Gross Profit

-$5M-35700.0% margin

Operating Income

-$14M-93746.7% margin

Net Income

-$12M-83013.3% margin

EPS (Diluted)

$-32801.22

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$314,000

Balance Sheet

Total Assets

$4M

Total Liabilities

$2M

Stockholders' Equity

$2M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15,000	$19,000	-21.1%
Gross Profit	-$5M	-$5M	+0.8%
Operating Income	-$14M	-$9M	-56.0%
Net Income	-$12M	-$9M	-38.4%